State of Wyoming »

Allogene Therapeutics shares owned by State of Wyoming

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by State of Wyoming from 13F filings

Historical chart of State of Wyoming investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by State of Wyoming consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by State of Wyoming

Quarter filed Position value Share count Share price at filing
2026-06-30 $70k 34k 2.08

More positions owned by State of Wyoming

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Msci Emrg Chn (EMXC)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Msci Taiwan Etf (EWT)
Alphabet Cap Stk Cl C (GOOG)
Marvell Technology (MRVL)
Micron Technology (MU)
Interactive Brokers Group In Com Cl A (IBKR)
Meta Platforms Cl A (META)
Incyte Corporation (INCY)
Tower Semiconductor Shs New (TSEM)

View all positions for State of Wyoming

Top funds holding Allogene Therapeutics

BlackRock
Frazier Life Sciences Management
Pfizer
Tpg Gp A
Sio Capital Management
PRIMECAP Management Company
Vanguard Capital Management
FMR
Citadel Advisors
State Street Corporation
Two Sigma Investments
Geode Capital Management
Goldman Sachs Group
T. Rowe Price Associates
Marshall Wace

View all funds holding Allogene Therapeutics